Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

48.87
+0.54001.12%
Pre-market: 49.350.4750+0.97%07:32 EDT
Volume:1.30M
Turnover:63.10M
Market Cap:8.20B
PE:125.88
High:49.03
Open:48.05
Low:47.64
Close:48.33
52wk High:55.67
52wk Low:25.17
Shares:167.76M
Float Shares:155.00M
Volume Ratio:1.11
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:4.53
PE(LYR):34.17

Loading ...

UBS Adjusts Price Target on Alkermes Public to $48 From $42, Maintains Buy Rating

MT Newswires Live
·
May 06

Alkermes (ALKS) Receives a Buy from Wells Fargo

TIPRANKS
·
May 06

Alkermes Plc : Needham Raises Target Price to $50 From $45

THOMSON REUTERS
·
May 06

Alkermes Is Maintained at Buy by Needham

Dow Jones
·
May 06

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Tenaya Therapeutics (TNYA)

TIPRANKS
·
May 06

Stock Track | Alkermes PLC Soars 5.03% Intraday on Strong Q1 Earnings Beat and Phase 3 Clinical Program Initiation

Stock Track
·
May 06

GUIDANCE: (ALKS) Alkermes Expects 2026 Revenue Range $1.73B - $1.84B, vs. FactSet Est of $1.80B

MT Newswires Live
·
May 05

Earnings Flash (ALKS) Alkermes Posts Q1 Net Loss $0.40 a Share, vs. FactSet Est of $0.58 Loss

MT Newswires Live
·
May 05

Alkermes Q1 FY26 net loss widens to $66.5 million; revenue climbs to $392.9 million

Reuters
·
May 05

Alkermes Plc Q1 Total Revenue $392.9 Mln

THOMSON REUTERS
·
May 05

Alkermes Plc Q1 Shr Loss 0.40

THOMSON REUTERS
·
May 05

Alkermes Q1 EPS $(0.40) Beats $(0.52) Estimate, Sales $392.911M Beat $359.848M Estimate

Benzinga Earnings
·
May 05

Alkermes Plc: Alixorexton Brilliance Phase 3 Narcolepsy Clinical Program Initiated in Q1 2026

THOMSON REUTERS
·
May 05

Alkermes Plc Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 05

Press Release: Alkermes plc Reports First Quarter 2026 Financial Results

Dow Jones
·
May 05

Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $67,528.8

Reuters
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Alkermes CMO Craig Hopkinson disposes 9,000 shares for $300,559.5

Reuters
·
May 02

Earning Preview: Alkermes PLC revenue expected to increase by 18.33% this quarter, institutions are broadly bullish

Earnings Agent
·
Apr 28

How Investors Are Reacting To Alkermes (ALKS) Strong Alixorexton Orexin-2 Data And Broader CNS Ambitions

Simply Wall St.
·
Apr 27